2005
DOI: 10.1373/clinchem.2005.049932
|View full text |Cite
|
Sign up to set email alerts
|

Pyrosequencing Analysis of Thrombosis-Associated Risk Markers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 13 publications
1
12
0
Order By: Relevance
“…All loci were amplified in an outer 10-plex PCR followed by an inner 10-plex PCR for genotyping with PrASE and also 10 inner simplex PCR reactions for genotyping with Pyrosequencing. Pyrosequencing was performed as previously described [17]. A 99.8 % concordance was achieved between the two assays.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…All loci were amplified in an outer 10-plex PCR followed by an inner 10-plex PCR for genotyping with PrASE and also 10 inner simplex PCR reactions for genotyping with Pyrosequencing. Pyrosequencing was performed as previously described [17]. A 99.8 % concordance was achieved between the two assays.…”
Section: Resultsmentioning
confidence: 99%
“…DNA was extracted from blood from unrelated individuals of Caucasian/Scandinavian origin (from a cohort of patients presenting with symptoms of acute chest pain) [17]. The patients were included in the Carlscrona Heart Attack Prognosis Study approved by the ethics committee at the University of Lund, Sweden in compliance with the Declaration of Helsinki.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Allele-specific loading of Pol II was evaluated by Pyrosequencing™ as described [13]. Briefly, DNA was amplified using primer pairs with one biotinylated 5' end (Table S3) [14]. The amplification products were captured on streptavidin coated sepharose beads (Amersham Biosciences AB, Uppsala, Sweden), denatured and then washed.…”
Section: Methodsmentioning
confidence: 99%
“…A pyrosequencing-based genotype platform that analyzes common prothrombotic, hemostatic, and treatment-modulating mutations may represent an optimized diagnostic strategy for analysis ( Holmberg et al, 2005 ), with potential application in both epidemiologic studies and clinical diagnosis ( Mooser et al, 2003 ).…”
Section: Emerging Platform For Hemostasis and Thrombosis Researchmentioning
confidence: 99%